BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11175837)

  • 21. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
    Ozaki NK; Beharry KD; Nishihara KC; Akmal Y; Ang JG; Sheikh R; Modanlou HD
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis.
    Breier G
    Adv Exp Med Biol; 2000; 476():57-66. PubMed ID: 10949655
    [No Abstract]   [Full Text] [Related]  

  • 27. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
    McColl BK; Baldwin ME; Roufail S; Freeman C; Moritz RL; Simpson RJ; Alitalo K; Stacker SA; Achen MG
    J Exp Med; 2003 Sep; 198(6):863-8. PubMed ID: 12963694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
    Karpanen T; Egeblad M; Karkkainen MJ; Kubo H; Ylä-Herttuala S; Jäättelä M; Alitalo K
    Cancer Res; 2001 Mar; 61(5):1786-90. PubMed ID: 11280723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L; Catalano A; Vianale G; Orecchia S; Casalini A; Tassi G; Puntoni R; Mutti L; Procopio A
    J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
    Catalano A; Romano M; Martinotti S; Procopio A
    Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
    Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF receptor signaling and endothelial function.
    Kliche S; Waltenberger J
    IUBMB Life; 2001 Jul; 52(1-2):61-6. PubMed ID: 11795595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis.
    Achen MG; Williams RA; Minekus MP; Thornton GE; Stenvers K; Rogers PA; Lederman F; Roufail S; Stacker SA
    J Pathol; 2001 Feb; 193(2):147-54. PubMed ID: 11180159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eye and pathologic angiogenesis].
    Ishibashi T
    Fukuoka Igaku Zasshi; 2000 Nov; 91(11):277-83. PubMed ID: 11187718
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphatic vessels as targets of tumor therapy?
    Karpanen T; Alitalo K
    J Exp Med; 2001 Sep; 194(6):F37-42. PubMed ID: 11561002
    [No Abstract]   [Full Text] [Related]  

  • 39. Variations on ligand-receptor complexes.
    Wiesmann C; de Vos AM
    Nat Struct Biol; 2000 Jun; 7(6):440-2. PubMed ID: 10881184
    [No Abstract]   [Full Text] [Related]  

  • 40. Current biology of VEGF-B and VEGF-C.
    Olofsson B; Jeltsch M; Eriksson U; Alitalo K
    Curr Opin Biotechnol; 1999 Dec; 10(6):528-35. PubMed ID: 10600689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.